Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization

被引：0
|
作者：
Prooksa Ananchuensook
Supachaya Sriphoosanaphan
Sirinporn Suksawatamnauy
Nipaporn Siripon
Nutcha Pinjaroen
Nopavut Geratikornsupuk
Stephen J. Kerr
Kessarin Thanapirom
Piyawat Komolmit
机构：
[1] Chulalongkorn University,Division of Gastroenterology, Department of Medicine, Faculty of Medicine
[2] King Chulalongkorn Memorial Hospital,Center of Excellence in Liver Diseases
[3] Thai Red Cross Society,Liver Fibrosis and Cirrhosis Research Unit
[4] Chulalongkorn University,Department of Radiology, Faculty of Medicine
[5] Chulalongkorn University,Department of Medicine
[6] Queen Savang Vadhana Memorial Hospital,Center of Excellence in Biostatistics, Faculty of Medicine
[7] Chulalongkorn University,undefined
来源：
BMC Gastroenterology | / 22卷
关键词：
Easy albumin-bilirubin score; Intermediate-stage hepatocellular carcinoma; Trans-arterial chemoembolization; Overall survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Optimal timing of combining sorafenib with trans-arterial chemoembolization in patients with hepatocellular carcinoma: A meta-analysis
    Dai, Yanmei
    Jiang, Huijie
    Jiang, Hao
    Zhao, Sheng
    Zeng, Xu
    Sun, Ran
    Zheng, Ruoshui
    TRANSLATIONAL ONCOLOGY, 2021, 14 (12):
  • [32] Validation of a Modified Substaging System (Kinki Criteria) for Patients with Intermediate-Stage Hepatocellular Carcinoma
    Arizumi, Tadaaki
    Ueshima, Kazuomi
    Iwanishi, Mina
    Minami, Tomohiro
    Chishina, Hirokazu
    Kono, Masashi
    Takita, Masahiro
    Kitai, Satoshi
    Inoue, Tatsuo
    Yada, Norihisa
    Hagiwara, Satoru
    Ida, Hiroshi
    Minami, Yasunori
    Sakurai, Toshiharu
    Kitano, Masayuki
    Nishida, Naoshi
    Kudo, Masatoshi
    ONCOLOGY, 2015, 89 : 47 - 52
  • [33] Analyses of Intermediate-Stage Hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolization prior to Designing Clinical Trials
    Koroki, Keisuke
    Ogasawara, Sadahisa
    Ooka, Yoshihiko
    Kanzaki, Hiroaki
    Kanayama, Kengo
    Maruta, Susumu
    Maeda, Takahiro
    Yokoyama, Masayuki
    Wakamatsu, Toru
    Inoue, Masanori
    Kobayashi, Kazufumi
    Kiyono, Soichiro
    Nakamura, Masato
    Kanogawa, Naoya
    Saito, Tomoko
    Kondo, Takayuki
    Suzuki, Eiichiro
    Nakamoto, Shingo
    Yasui, Shin
    Tawada, Akinobu
    Chiba, Tetsuhiro
    Arai, Makoto
    Kanda, Tatsuo
    Maruyama, Hitoshi
    Kato, Jun
    Kuboki, Satoshi
    Ohtsuka, Masayuki
    Miyazaki, Masaru
    Yokosuka, Osamu
    Kato, Naoya
    LIVER CANCER, 2020, 9 (05) : 596 - 612
  • [34] Sarcopenia as a prognostic factor in patients with hepatocellular carcinoma treated with transcatheter arterial chemoembolization plus sorafenib
    Wang, Rujian
    Wang, Ligang
    Jiang, Yutian
    Dong, Mei
    Li, Mei
    Sun, Ping
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2024, 20 (04) : 1208 - 1213
  • [35] Development of a Model to Predict Liver Decompensation prior to Transarterial Chemoembolization Refractoriness in Patients with Intermediate-Stage Hepatocellular Carcinoma
    Ferreira-Silva, Joel
    Costa-Moreira, Pedro
    Cardoso, Helder
    Liberal, Rodrigo
    Pereira, Pedro
    Macedo, Guilherme
    GE PORTUGUESE JOURNAL OF GASTROENTEROLOGY, 2023, 30 (01) : 29 - 37
  • [36] Prognostic sub-classification of intermediate-stage hepatocellular carcinoma: a multicenter cohort study with propensity score analysis
    Ramaswami, Ramya
    Pinato, David J.
    Kubota, Keiichi
    Ishizuka, Mitsuru
    Arizumi, Tadaaki
    Kudo, Masatoshi
    Jang, Jeong Won
    Kim, Young Woon
    Pirisi, Mario
    Allara, Elias
    Sharma, Rohini
    MEDICAL ONCOLOGY, 2016, 33 (10)
  • [37] Prognostic sub-classification of intermediate-stage hepatocellular carcinoma: a multicenter cohort study with propensity score analysis
    Ramya Ramaswami
    David J. Pinato
    Keiichi Kubota
    Mitsuru Ishizuka
    Tadaaki Arizumi
    Masatoshi Kudo
    Jeong Won Jang
    Young Woon Kim
    Mario Pirisi
    Elias Allara
    Rohini Sharma
    Medical Oncology, 2016, 33
  • [38] Validation of the ALBI-TAE model and comparison of seven scoring systems for predicting survival outcome in patients with intermediate‐stage hepatocellular carcinoma undergoing chemoembolization
    Kittipitch Bannangkoon
    Keerati Hongsakul
    Teeravut Tubtawee
    Cancer Imaging, 23
  • [39] Combined stereotactic body radiotherapy and trans-arterial chemoembolization as initial treatment in BCLC stage B-C hepatocellular carcinoma
    Chiang, C. L.
    Chan, Mark K. H.
    Yeung, Cynthia S. Y.
    Ho, Connie H. M.
    Lee, Francis A. S.
    Lee, Venus W. Y.
    Wong, Frank C. S.
    Blanck, Oliver
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 (03) : 254 - 264
  • [40] Serum miR-335 Level is Associated with the Treatment Response to Trans-Arterial Chemoembolization and Prognosis in Patients with Hepatocellular Carcinoma
    Cui, Liming
    Hu, Yue
    Bai, Bin
    Zhang, Shide
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2015, 37 (01) : 276 - 283
12345